Same-day discharge after coronary stenting: A feasibility study using a hemostatic femoral puncture closure device

Journal of Interventional Cardiology

Volumn 17, Issue 5, 2004, Pages 315-320

  Yee, Kok Meng ^a   Lazzam, Charles ^a   Richards, Jan ^a   Ross, John ^a   Seidelin, Peter H ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CORONARY ARTERY DISEASE; CORONARY STENT; DEVICE; FALSE ANEURYSM; FEMALE; FEMORAL ARTERY; FOLLOW UP; HEMATOMA; HEMOSTASIS; HOSPITAL DISCHARGE; HUMAN; INFECTION; INGUINAL REGION; MAJOR CLINICAL STUDY; MALE; MOBILIZATION; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; VASCULAR SURGERY;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CASE-CONTROL STUDIES; CORONARY ARTERIOSCLEROSIS; FEASIBILITY STUDIES; FEMALE; FEMORAL ARTERY; FOLLOW-UP STUDIES; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PATIENT DISCHARGE; PATIENT SELECTION; PILOT PROJECTS; STENTS; TREATMENT OUTCOME;

EID: 7244249980     PISSN: 08964327     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2004.00232.x     Document Type: Article

References (18)

1. Koch KT, Piek JJ, Prins MH, et al. Triage of patients for short term observation after elective coronary angioplasty. Heart 2000;83:557-563.
2. Kiemeneij F, Laarman GJ, Slagboom T, et al. Outpatient coronary stent implantation. J Am Coll Cardiol 1997;29:323-327.
3. Slagboom T, Kiemenij F, Laarman GJ, et al. Actual outpatient PTCA: Results of the OUTCLAS pilot study. Catheter Cardiovasc Interv 2001;53:204-208.
4. de Swart H, Dijkman L, Hofstra L, et al. A new hemostatic puncture closure device for the immediate sealing of arterial puncture sites. Am J Cardiol 1993;72:445-449.
5. Aker UT, Kensey KR, Heuser RR, et al. Immediate arterial hemostasis after cardiac catheterization: Initial experience with a new puncture closure device. Catheter Cardiovasc Diag 1994;31:228-232.
6. Kensey KR. Puncture site hemostasis. J Invasive Cardiol 1994;6(8):273-276.
7. Kussmaul WG, Buchbinder M, Whitlow PL, et al. Rapid arterial hemostasis and decreased access site complications after cardiac catheterization and angioplasty: Results of a randomized trial of a novel hemostatic device. J Am Coll Cardiol 1995;25:1685-1692.
8. Silber S, Zindler G, Dorr R, et al. Intra-arterial anchoring is superior to plain collagen plugging for sealing arterial puncture sites and ambulating after 20 minutes. Circulation 1995;92(Suppl. I)(8):1-225.
9. Seidelin PH, Adelman AG. Mobilization within 30 minutes of elective diagnostic coronary angiography: A feasibility study using a hemostatic femoral puncture closure device. J Interven Cardiol 1997;10:409-415.
10. Wilentz JR, McDermott DRN, Ravi K, et al. Outpatient coronary stenting using the femoral approach with vascular sealing. J Invas Cardiol 1999;11:709-717.
11. Carere RG, Webb JG, Buller CEH, et al. Suture closure of femoral arterial puncture sites after coronary angioplasty followed by same-day discharge. Am Heart J 2000;139:52-58.
12. The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994;330:956-961.
13. The EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low dose heparin during percutaneous coronary revascularisation. N Engl J Med 1997;336:1689-1696.
14. The EPISTENT Investigators. Randomized placebo controlled and balloon angioplasty controlled trial to assess safety of coronary stenting with use of platelet glycoprotein IIb/IIIa blockade. Lancet 1998;352:87-92.
15. Hamm CW, Heeschen C, Goldmann B, et al. for the CAPTURE Study Investigators. Benefit of abciximab in patients with refractory unstable angina in relation to serum Troponin T levels. N Engl J Med 1999;340:1623-1629.
16. The PRISM Study Investigators. Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. Lancet 1999;354:1757-1762.
17. Mehta S, Popma J, Margolis JR, et al. Complications with new angioplasty devices. Are these device specific? J Am Coll Cardiol 1996;27(Suppl A):168A.
18. Roubin GS, Lin S, Niederman A, et al. Clinical and anatomic descriptors for a major complication following PTCA. J Am Coll Cardiol 1987;9:20A.